Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
The pathophysiologic basis for spastic Raynaud's syndrome remains undefined but may be related to altered adrenergic activity. The relationship between Raynaud's syndrome and alterations in adrenergic receptor populations was examined in the present study by evaluation of alpha 2-adrenergic receptors in platelets. Direct binding assays revealed 78 +/- 8 fm/mg protein of alpha 2-adrenergic receptors in the platelets from control subjects. Similar levels of alpha 2-adrenergic receptors were observed in patients with obstructive Raynaud's syndrome. In contrast, platelet alpha 2-adrenergic receptor levels were significantly elevated (182 +/- 15 fm/mg protein) in the platelets from patients with spastic Raynaud's syndrome. These results indicate the presence of an altered alpha 2-adrenergic receptor population in the platelets from patients with spastic Raynaud's syndrome, which may be related to the vasospasm experienced by these patients.
D000328:Adult; D000818:Animals; D001161:Arteriosclerosis / Q000150:complications; D001681:Biological Assay; D001792:Blood Platelets / Q000032:analysis*; D001794:Blood Pressure; D003080:Cold Temperature; D005260:Female; D005385:Fingers / Q000098:blood supply; D006801:Humans; D008297:Male; D008875:Middle Aged; D011817:Rabbits; D011928:Raynaud Disease / Q000097:blood* / Q000145:classification / Q000150:complications; D011941:Receptors, Adrenergic / Q000032:analysis*; D011942:Receptors, Adrenergic, alpha / Q000032:analysis*; D012595:Scleroderma, Systemic / Q000150:complications; D012737:Sex Factors
D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha